Farallon Capital Management is a global multi-strategy hedge fund headquartered in San Francisco. With over 35 years of investment experience and $39 billion in capital under management, the firm focuses on a diverse range of investment strategies across various sectors and geographies. Farallon emphasizes alignment between its people, investors, and business partners.

The firm's portfolio includes notable companies such as Beam Therapeutics, Freenome, and Sea. Farallon has invested in various stages, from Series A to Post-IPO rounds, with a particular focus on Series C and D investments. The firm's approach is characterized by a strong emphasis on values, culture, and relationships, leveraging its extensive experience and reputation in the investment industry.